Steering Board

Equally representing the sites of Munich, Münster and the Rhine-Main Neuroscience Network (rmn2), the role of the Steering Board is to – amongst other things – coordinate the needs of the individual research groups; examine membership applications; and present project and funding requests to the DFG on behalf of the CRC.

 

Prof. Dr. Heinz Wiendl Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl (Münster), Spokesperson
Klinik für Neurologie
Universitätsklinikum der
Westfälischen Wilhelms-Universität Münster
E-Mail: heinz.wiendl@ukmuenster.de

 

 

 

Prof. Dr. Frauke ZippUniv-Prof. Dr. med. Frauke Zipp (rmn2), Co-Spokesperson
Klinik und Poliklinik für Neurologie
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: frauke.zipp@unimedizin-mainz.de

 

 

 

Prof. Martin Kerschensteiner width=Prof. Dr. Martin Kerschensteiner, Secretary
Institut für klinische Neuroimmunologie
Ludwig-Maximilians-Universität München
E-Mail: martin.kerschensteiner@med.uni-muenchen.de

 

 

 

 

Prof. Dr. Thomas Korn Prof. Dr. Thomas Korn
Neurologische Klinik und Poliklinik
Klinikum Rechts der Isar
Technische Universität München
E-Mail: thomas.korn@tum.de

 

 

 

Prof. Lydia Sorokin, PhDUniv.-Prof. Dr. rer. nat. Lydia Sorokin
Institut für Physiologische Chemie und Pathobiochemie
Westfälische Wilhelms-Universität Münster
E-Mail: sorokin@uni-muenster.de

 

 

 

 

Prof. Ari Waisman, PhD Univ.-Prof. Dr. rer. nat. Ari Waisman, PhD
Institut für Molekulare Medizin,
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: waisman@uni-mainz.de

News

Tue, 04/12/2018
SFB 128 International Symposium
SFB 128. We are happy to announce the international Symposium of the Collaborative Research Centre 128 “Multiple Sclerosis” taking place from Sunday, September 15th, till Tuesday, September 17th, 2019 in the Rhine Main region. Full details of the event will follow....more
Fri, 26/10/2018
Featured publication: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
In a large multi-cohort study, performed by the International Multiple Sclerosis Genetics Consortium (IMSGC) and published in Cell Magazine, unexplained heritability for multiple sclerosis (MS) is detected in low-frequency coding variants that are missed by genome-wide association study (GWAS) analyses, further underscoring the role of immune genes in MS pathology. The IMSGC was formed in […]...more
Tue, 09/10/2018
Munich Cluster for Systems Neurology (SyNergy) will be funded
Munich. The Cluster for Systems Neurology (SyNergy) by LMU and TUM will receive funding from 2019 on. Currently SFB PIs Prof. Reinhard Hohlfeld, Prof. Martin Kerschensteiner, Prof. Mikael Simons are also PIs of SyNergy projects....more